Interfant-21: New trial for infants with ALL launched in Belgium
A new trial for infants (<1 year) with KMT2A‐rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia launched in Belgium.
The BSPHO unites the recognized Belgian centres in paediatric haemato-oncology and their professionals to share expertise and knowledge to improve treatment and patient care in childhood cancer
A new trial for infants (<1 year) with KMT2A‐rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia launched in Belgium.
The BSPHO Scientific Meeting on 20 September featured key insights into pediatric haemato-oncology research. See topics discussed and event photos.
Participate in the e-Quol survey to help enhance digital health tools for young cancer survivors and their loved ones.
The CAYA policy brief publication outlines key recommendations to improve care and outcomes for young cancer patients.